Docteur MARIE-CHRISTINE MOAL

Bibliographie

• Association between mycophenolic acid treatment and infection with specific strains of Pneumocystis jirovecii in solid organ transplant recipients in France and Switzerland: a multicentre, retrospective, cross-sectional study

  2025

  ArticleThe Lancet Microbe

• Merkel cell carcinoma from renal transplant recipients are mostly MCPyV ‐negative and are frequently associated with squamous cell carcinomas or precursors

  2023

  ArticleJournal of the European Academy of Dermatology and Venereology

• Selection of Pneumocystis jirovecii Inosine 5′-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid

  2021

  ArticleJournal of Fungi

• The shift from pulmonary colonization to Pneumocystis pneumonia

  2020

  ArticleMedical Mycology

• Pneumocystis jirovecii Exhalation in the Course of Pneumocystis Pneumonia Treatment

  2018

  ArticleInfection Control & Hospital Epidemiology

• The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients

  2016

  ArticleNephrology Dialysis Transplantation

• The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease

  2016

  ArticleJournal of the American Society of Nephrology

• Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.

  2014

  ArticleAnnals of Transplantation

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Livres & ouvrages

• 📕

  Etude comparative des lésions radiologiques de la polyarthrite rhumatoïde en fonction de la présence ou de l'absence de facteurs rhumatoïdes IgA

  1989

Source : Google Books — filtre catégories médicales/santé/sciences.

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Belatacept and Long-Term Outcomes in Kidney Transplantation

  The New England journal of medicine · 2016

  📚 589 citations🎯 RCR 22.69Top 1% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗
• 2

  The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease

  Journal of the American Society of Nephrology : JASN · 2016

  📚 286 citations🎯 RCR 11.52Top 2% NIH🔓 Open Access
• 3

  Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2013

  📚 117 citations🎯 RCR 4.19Top 10% NIH🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  Purpose Post-transplantation lymphoproliferative disorder (PTLD) is associated with significant mortality in kidney transplant recipients. We conducted a prospective survey of the occurrence of PTLD in a French nationwide population of adult kidney recipients over 10 years. Patients and Methods A French registry was established to cover a nationwide population of transplant recipients and prospectively enroll all adult kidney recipients who developed PTLD between January 1, 1998, and December 31, 2007. Five hundred patient cases of PTLD were referred to the French registry. The prognostic factors for PTLD were investigated using Kaplan-Meier and Cox analyses. Results Patients with PTLD had a 5-year survival rate of 53% and 10-year survival rate of 45%. Multivariable analyses revealed that age > 55 years, serum creatinine level > 133 μmol/L, elevated lactate dehydrogenase levels, disseminated lymphoma, brain localization, invasion of serous membranes, monomorphic PTLD, and T-cell PTLD were independent prognostic indicators of poor survival. Considering five variables at diagnosis (age, serum creatinine, lactate dehydrogenase, PTLD localization, and histology), we constructed a prognostic score that classified patients with PTLD as being at low, moderate, high, or very high risk for death. The 10-year survival rate was 85% for low-, 80% for moderate-, 56% for high-, and 0% for very high–risk recipients. Conclusion This nationwide study highlights the prognostic factors for PTLD and enables the development of a new prognostic score. After validation in an independent cohort, the use of this score should allow treatment strategies to be better tailored to individual patients in the future.

Publications scientifiques (17) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche